Injective (INJ) is currently priced at $3.63, reflecting a 5.36% increase over the past 24 hours. The daily trading range has been relatively tight, with a high of $3.68 and a low of $3.41, indicating a daily volatility of approximately 7.38%.

The volume of 54,028,815 INJ traded corresponds to a volume-to-market cap ratio of 14.90%, suggesting a healthy level of trading activity relative to its market capitalization. Short-term moving averages show a bullish trend, with the 8 SMA at $3.52 and a 3.09% increase, while longer-term averages like the 144 SMA at $3.57 indicate a slight upward momentum of 1.70%.

The 1-hour RSI is significantly high at 83, indicating that INJ may be overbought in the very short term, while the 7-day RSI at 50 suggests that the asset is in a neutral position overall. The price changes over the past 7, 14, and 30 days—5.58%, 6.66%, and 23.09%, respectively—demonstrate a strong upward trend in the medium to long term.

Given the significant price movements and the current market conditions, INJ appears to be on an upward trajectory, though caution is warranted due to the overbought signal from the 1-hour RSI. The proximity to the daily high suggests potential resistance, but the positive momentum across moving averages indicates continued buying interest.

In conclusion, while there may be short-term pullback risks, the overall trend and volume support further price appreciation. Therefore, the recommendation is to Buy INJ, as the fundamentals and technical indicators suggest favorable conditions for price growth in the near term.